Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

ClinicalTrials.gov ID: NCT00425256

Public ClinicalTrials.gov record NCT00425256. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00425256
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Palatin Technologies, Inc
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Bremelanotide Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 70 Years
Sex
Female
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2006
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
Feb 22, 2011

2006 – 2007

United States locations

U.S. sites
20
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Medical Affiliated Research Center Huntsville Alabama
Quality of Life Medical & Research Center, LLC Tucson Arizona
University of California, Department of Family and Preventative Medicine La Jolla California
Downtown Women's Health Care Denver Colorado
Coastal Connecticut Research New London Connecticut
South Florida Medical Research Aventura Florida
Clinical Study Center Fort Myers Florida
Center For Marital and Sexual Health of South Florida West Palm Beach Florida
Northeast Indiana Research Fort Wayne Indiana
Center for Sexual Medicine at Sheppard Pratt Baltimore Maryland
Advanced Biomedical Research, Inc Hackensack New Jersey
The Center for Female Sexuality Purchase New York
Wake Research Associates, LLC Raleigh North Carolina
Lyndhurst Gynecologic Associates Winston-Salem North Carolina
The Ohio State University Columbus Ohio
Medford Women's Clinic, LLP Medford Oregon
Clinical Trials Research Services, LLC Pittsburgh Pennsylvania
Advanced Clinical Therapies, Inc. West Reading Pennsylvania
Accelovance Houston Texas
Women's Clinical Research Center Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00425256, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00425256 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →